Statistical methods and analyses in autoimmune diseases by Inshaw, J

Comparison of methods for transcriptome imputation through application to two common complex diseases by Fryett, J, Inshaw, J, Morris, A, Cordell, H

The chromosome 6q22.33 region is associated with age at diagnosis of type 1 diabetes and disease risk in those diagnosed under 5 years of age. by Inshaw, J, Walker, N, Wallace, C, Bottolo, L, Todd, J

Genetic variants predisposing most strongly to type 1 diabetes diagnosed under age 7 years lie near candidate genes that function in the immune system and in pancreatic β-cells by Inshaw, J, Cutler, A, Crouch, D, Wicker, L, Todd, J

A global-local approach for detecting hotspots in multiple-response regression by Ruffieux, H, Davison, AC, Hager, J, Inshaw, J, Fairfax, BP, Richardson, S, Bottolo, L

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters by Gossez, M, Martin, GE, Pace, M, Ramjee, G, Premraj, A, Kaleebu, P, Rees, H, Inshaw, J, Stöhr, W, Meyerowitz, J, Hopkins, E, Jones, M, Hurst, J, Porter, K, Babiker, A, Fidler, S, Frater, J, Spartac Trial Investigators

The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes by Ramos-Rodríguez, M, Raurell-Vila, H, Colli, M, Alvelos, M, Subirana, M, Juan-Mateu, J, Norris, R, Turatsinze, J, Nakayasu, E, Webb-Robertson, B, Inshaw, J, Marchetti, P, Piemonti, L, Esteller, M, Todd, J, Metz, T, Eizirik, D, Pasquali, L

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial by BREATHER (PENTA 16) Trial Group

Other Authors: “…Inshaw, J…”